Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

285
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
285
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

20
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing...
20
Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

17
The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration,...
17
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

18
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
18
Modeling with Differential Equations01:25

Modeling with Differential Equations

98
Population dynamics can be described mathematically by considering the population size P(t) as a function of time. The rate of change of the population is then represented by the derivative of P(t). A simple assumption is that the rate of growth is proportional to the size of the population itself. This leads to an exponential growth model, where the population increases rapidly without bound. While this is a useful first approximation, it does not reflect realistic long-term...
98

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Cost-effectiveness of a decentralised molecular point-of-care testing programme for sexually transmitted infections in remote primary care health services in Australia.

Sexually transmitted infections·2026
Same author

Hantavirus outbreak on a cruise ship in the South Atlantic.

Lancet (London, England)·2026
Same author

Respiratory syncytial virus (RSV) vaccination program for older Australians reduces health inequalities: a distributional cost-effectiveness analysis.

Vaccine·2026
Same author

Ensemble forecasts of COVID-19 activity to support Australia's pandemic response: 2020-22.

PLoS computational biology·2026
Same author

Estimating the cost-effectiveness of respiratory syncytial virus (RSV) vaccination program for older Australian adults.

Vaccine·2026
Same author

Capturing SARS-CoV-2 immune landscapes to inform future strategies for COVID-19 vaccination in a high-income setting: a mathematical modelling study.

BMC infectious diseases·2026

関連する実験動画

Updated: Feb 17, 2026

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
08:04

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Published on: February 8, 2019

9.1K

ホスト内の数学モデルを使用して,淋病の治療効果をシミュレートする.

Pavithra Jayasundara1, David G Regan2, Philip Kuchel3

  • 1School of Population Health, UNSW Sydney, NSW, Australia.

Infectious Disease Modelling
|February 16, 2026
PubMed
まとめ

ネイセリア・ゴンノレア (NG) の抗生物質耐性は,新しい治療法を必要としています. 数学的モデルによると,細胞内細菌のクリアランスは,細胞外薬レベルだけでなく,治療の成功の鍵です. ゲポチダシンと併用療法が有望であることが示されています.

キーワード:
アジトロマイシン (Azithromycin) とはアジトロマイシン (Azithromycin) とはアジトロマイシン (Azithromycin) とはアジトロマイシン (Azithromycin) とはゲンタミシンはゲポチダシン (Gepotidacin) とはゴノレア・ゴノレアとはイントラセルラー細胞内薬学動力学的な効果がある.ファルマコキネティクスは,

さらに関連する動画

Using Single-Worm Data to Quantify Heterogeneity in Caenorhabditis elegans-Bacterial Interactions
09:54

Using Single-Worm Data to Quantify Heterogeneity in Caenorhabditis elegans-Bacterial Interactions

Published on: July 22, 2022

3.7K
Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria
08:53

Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria

Published on: May 25, 2022

4.6K

関連する実験動画

Last Updated: Feb 17, 2026

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
08:04

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Published on: February 8, 2019

9.1K
Using Single-Worm Data to Quantify Heterogeneity in Caenorhabditis elegans-Bacterial Interactions
09:54

Using Single-Worm Data to Quantify Heterogeneity in Caenorhabditis elegans-Bacterial Interactions

Published on: July 22, 2022

3.7K
Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria
08:53

Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria

Published on: May 25, 2022

4.6K

科学分野:

  • 微生物学 微生物学とは
  • 薬理学 薬理学とは
  • 数学的モデリング

背景:

  • ネイセリア・ゴンノレア (NG) は,広範な抗生物質耐性を示しています.
  • 淋病の既存の治療法は,効果が低下しています.
  • 数学的モデリングは,治療の結果を予測することができます.

研究 の 目的:

  • ホスト内の数学モデルを拡張して,薬物動力学/薬物動力学 (PK/PD) 治療ダイナミクスを含む.
  • ゴノレアのゲポチダシン単独治療とジェンタミシン/アジトロミシン二重治療を調査する.
  • 治療の成功を予測するPK/PD指標を特定する.

主な方法:

  • PK/PDの特徴を組み込んだ拡張されたホスト内数学モデルを開発しました.
  • ゲポチダシンとジェンタミシン/アジトロミシンのためのシミュレーションされた治療レジメン.
  • PK指数 (例えば,AUC/MIC) と治療結果との関係を分析した.
  • 治療の成功における細胞内NGクリアランスの役割を評価した.

主要な成果:

  • シミュレーションによる治療の成功率は,利用可能な臨床データと相関しています.
  • 抗生物質の失敗は,細胞内NGの不完全なクリアランスに関連しています.
  • 細胞外PK指数だけでは,治療の成功/失敗を予測できませんでした.
  • 細胞内ゲポチダシンのAUC/MIC>150 予測された成功.
  • ダブルセラピーのAUC/MIC>140も成功率を予測したが,情報提供性は低かった.

結論:

  • 細胞内細菌負荷は,淋病の治療結果の決定的な要因です.
  • PK/PDモデリングは,特に細胞内薬物濃度を考えると,新しい抗生物質の評価に不可欠です.
  • 耐性菌株に対する効果的な治療法を開発するために,細胞内NGの殺戮に関するさらなる研究が必要である.